Skip to main content
Premium Trial:

Request an Annual Quote

GenoSense Licenses Genetic Technologies' DNA Patents; Firms Hint at Other Deals

NEW YORK (GenomeWeb News) — Genetic Technologies today said it has licensed its non-coding DNA patents to Viennese diagnostics company GenoSense.
Under the nine-year deal, GenoSense bought worldwide licensing rights to use Genetic Technologies’ technology in its anti-aging diagnostics and preventive testing services.
In a statement, the companies also said the “have identified a number of mutually beneficial global business opportunities that will be explored over the coming months.” The statement didn’t elaborate.
Financial terms of the agreement were not released.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.